Why the Atypical Symptoms in the Latest Monkeypox Cases? Experts agree these cases are unusual, but not necessarily a concern for viral mutation May 27, 2022
Oral Retinoid May Ease Painful Skin Reactions to Anticancer Therapy Preliminary data on acitretin therapy are promising May 11, 2022
In Lupus, 'Normal-Appearing' Skin Is Not Normal Groundwork for inflammation laid before lesions develop Apr 27, 2022
Testing for Th/To Antibodies May Help in Scleroderma Management Test identifies patients at high risk for pulmonary hypertension Apr 25, 2022
FDA OKs New Topical for Inflammatory Rosacea Almost half of patients clear of lesions or nearly so with benzoyl peroxide 5% cream (Epsolay) Apr 25, 2022
Smoker's Painless Skin Nodules Flag a Fatal Diagnosis Skin metastasis was the first sign for the otherwise asymptomatic patient Apr 04, 2022
First Topical Therapy for Facial Angiofibroma Nabs FDA Approval New alternative to dermabrasion, laser treatment, surgery Apr 04, 2022
Chronic Spontaneous Urticaria Responds Quickly to BTK Inhibitor AAD data also promising for therapies in psoriasis, pyoderma gangrenosum Mar 31, 2022
Meta-Analysis of Atopic Dermatitis Drugs Favors Two JAK Inhibitors Small advantages for abrocitinib, upadacitinib, but data still accumulating for all the players Mar 30, 2022
Toward More Uniform Methotrexate Dosing in Psoriasis International expert group urges common standards Mar 30, 2022
Jada Pinkett Smith's Alopecia The condition at the center of this year's Academy Awards drama Mar 29, 2022
Significant Improvement in Vitiligo With JAK Inhibitor Therapy Durable improvement in pigmentation with topical ruxolitinib, oral ritlecitinib Mar 29, 2022
Targeted Antibody Provides Significant Relief From Itchy Nodular Condition Dupilumab reduces itch, lesion count in first phase III trial for prurigo nodularis Mar 28, 2022
Dramatic, Durable Hair Growth With Oral JAK Inhibitor Oral baricitinib superior to placebo at 36 weeks in BRAVE-AA1 and BRAVE-AA2 trials Mar 27, 2022
Clinic-Based Hidradenitis Suppurativa Surgery Gets High Marks From Patients High satisfaction after three-fourths of procedures, despite frequent recurrences Mar 17, 2022
FDA Warns on Using Surgical Device for Aesthetic Skin Procedures Agency details potentially life-threatening adverse events with plasma-generating device Mar 14, 2022
Predicting Treatment Response in Inflammatory Muscle Disorders Swedish registry study elicits factors associated with improvement Feb 16, 2022
Acute Muscle Weakness and Skin Rash Following a Lupus Diagnosis Clinicians consider many differentials Feb 14, 2022
Two Years On, Tremfya Still Shines in Psoriatic Arthritis Efficacy increases in long-term extension data Feb 10, 2022
Hair Loss Drugs Ranked in Order of Efficacy Meta-analysis attempts a head-to-head comparison Feb 07, 2022
Evidence Begins to Gel for Atopic Dermatitis, Multiple Comorbid Conditions Atopic, metabolic, cardiovascular, and mental health conditions cited in guideline update Feb 02, 2022
Six Medical 鶹ýӰ With the Highest Hourly Wages Plastic and orthopedic surgery top the list Jan 27, 2022
Psoriasis Patients, Docs Want to Do More to Prevent Heart Problems Despite well-known cardiovascular risks, most patients currently undertreated Jan 19, 2022
FDA OKs Two Oral JAK Inhibitors for Refractory Atopic Dermatitis Once-daily abrocitinib and upadacitinib join topical ruxolitinib in expanding AD market Jan 18, 2022
IL-13 Inhibitor Approved for Adults With Atopic Dermatitis Significantly greater lesion clearance with tralokinumab in placebo-controlled studies Dec 28, 2021
Doc Fired After Standing Up to Private Equity; RFK Jr.'s Anti-Vax Machine This past week in healthcare investigations Dec 22, 2021
Think TikTok Is Smarter Than Me? Then I'm Not the Right Doctor for You Modern times have fundamentally altered the landscape of healthcare Nov 30, 2021
Signs of Relief From 'Therapeutic Drought' in Atopic Dermatitis Encouraging results from pipeline agents targeting Th2-specific inflammation Nov 09, 2021
Could This Biologic Drug Work in Patients Lacking Its Target? Bizarre finding with omalizumab Nov 07, 2021
Dramatic Responses in Cutaneous Sarcoidosis With JAK Inhibitor More than 80% reduction in disease activity in case series of tofacitinib treatment Nov 07, 2021
Substantial Improvement in Vitiligo With Topical JAK Inhibitor About 30% of patients had 75% clearance after 6 months, half had 50% clearance Nov 06, 2021
Early Success With New Target in Atopic Dermatitis Inhibition of Th2-related inflammation leads to rapid improvement in disease activity Nov 05, 2021
Topical PDE4 Inhibitor Impresses in Trial of Seborrheic Dermatitis Rapid, persistent improvement in body surface area, itch, other symptoms with roflumilast Nov 04, 2021
Botox Doc's License Suspended Over Breast, Penis Enhancement Harms One patient allegedly required two surgeries to fix penile enhancement gone wrong Oct 21, 2021
FDA to Make Isotretinoin Prescribing Gender Neutral Revision to risk management program dissociates gender from reproductive categories Oct 18, 2021
Is Private Equity a Dangerous Employer? Firms' investments in healthcare continue to expand, at what cost? Oct 14, 2021
FDA Warns on Needle-Free Injection Devices for Facial Fillers Serious injuries and "irreversible" harm to skin, lips, and eyes reported with unapproved devices Oct 08, 2021
FDA Issues Orders Clarifying Rules for Marketing Sunscreens But more studies on sunscreen chemicals are still needed, advocacy group says Sep 24, 2021
FDA Approves First Topical JAK Inhibitor for Atopic Dermatitis Significant skin clearance, reduced itch in majority of patients treated with ruxolitinib cream Sep 22, 2021
